Evidence map›Paper›PMID 33525682›Full record

ArticleInternational journal of molecular sciences2021

Expression of Endogenous Angiotensin-Converting Enzyme 2 in Human Induced Pluripotent Stem Cell-Derived Retinal Organoids.

Henkie Isahwan Ahmad Mulyadi Lai, Shih-Jie Chou, Yueh Chien, Ping-Hsing Tsai, Chian-Shiu Chien, Chih-Chien Hsu, Ying-Chun Jheng, Mong-Lien Wang, Shih-Hwa Chiou, Yu-Bai Chou and 4 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Stem cells for organoids.Smart medicine · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Organoid Studies in COVID-19 Research.International journal of stem cells · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Henkie Isahwan Ahmad Mulyadi LaiInstitute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan.ORCID 0000-0001-8516-743X
Shih-Jie ChouInstitute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan.ORCID 0000-0003-2610-8178
Yueh ChienDivision of Basic Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan.ORCID 0000-0002-1528-9252
Ping-Hsing TsaiInstitute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan.ORCID 0000-0003-2141-1872
Chian-Shiu ChienInstitute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan.ORCID 0000-0001-9666-1273
Chih-Chien HsuSchool of Medicine, National Yang-Ming University, Taipei 11217, Taiwan.ORCID 0000-0003-2354-2999
Ying-Chun JhengDivision of Basic Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan.ORCID 0000-0002-2883-4432
Mong-Lien WangDivision of Basic Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan.ORCID 0000-0002-4060-9131
Shih-Hwa ChiouInstitute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei 11217, Taiwan.
Yu-Bai ChouSchool of Medicine, National Yang-Ming University, Taipei 11217, Taiwan.
De-Kuang HwangSchool of Medicine, National Yang-Ming University, Taipei 11217, Taiwan.ORCID 0000-0001-6346-8485
Tai-Chi LinSchool of Medicine, National Yang-Ming University, Taipei 11217, Taiwan.
Shih-Jen ChenSchool of Medicine, National Yang-Ming University, Taipei 11217, Taiwan.
Yi-Ping YangDivision of Basic Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei 11217, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiotensin-converting enzyme 2 (ACE2) was identified as the main host cell receptor for the entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its subsequent infection. In some coronavirus disease 2019 (COVID-19) patients, it has been reported that the nervous tissues and the eyes were also affected. However, evidence supporting that the retina is a target tissue for SARS-CoV-2 infection is still lacking. This present study aimed to investigate whether ACE2 expression plays a role in human retinal neurons during SARS-CoV-2 infection. Human induced pluripotent stem cell (hiPSC)-derived retinal organoids and monolayer cultures derived from dissociated retinal organoids were generated. To validate the potential entry of SARS-CoV-2 infection in the retina, we showed that hiPSC-derived retinal organoids and monolayer cultures endogenously express ACE2 and transmembrane serine protease 2 (TMPRSS2) on the mRNA level. Immunofluorescence staining confirmed the protein expression of ACE2 and TMPRSS2 in retinal organoids and monolayer cultures. Furthermore, using the SARS-CoV-2 pseudovirus spike protein with GFP expression system, we found that retinal organoids and monolayer cultures can potentially be infected by the SARS-CoV-2 pseudovirus. Collectively, our findings highlighted the potential of iPSC-derived retinal organoids as the models for ACE2 receptor-based SARS-CoV-2 infection.

Indexed as

Gene ExpressionAngiotensin-Converting Enzyme 2Cell Culture TechniquesCell LineCOVID-19HumansInduced Pluripotent Stem CellsOrganoidsRetinaSARS-CoV-2Serine EndopeptidasesVirus InternalizationACE2 protein, humanAngiotensin-Converting Enzyme 2Serine EndopeptidasesTMPRSS2 protein, humanACE2COVID-19induced pluripotent stem cellsorganoidsSARS-CoV-2SARS-CoV-2 pseudovirusspike protein

Identifiers

PMID33525682
PMCPMC7865454

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.